Essential Role of Pharmacists in Asthma Care and Management

被引:37
作者
Bridgeman, Mary B. [1 ]
Wilken, Lori A. [2 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharm Practice & Adm, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
关键词
asthma; clinical outcomes; inhaler; pharmacists; primary care; PHARMACEUTICAL CARE; POOR ASTHMA; INHALED CORTICOSTEROIDS; COMMUNITY PHARMACY; COST-EFFECTIVENESS; CHILDREN; OUTPATIENT; SERVICES; IMPACT; ADULTS;
D O I
10.1177/0897190020927274
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Asthma, a chronic respiratory disease characterized by chronic airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, poses a substantial economic burden on patients and caregivers alike. Moreover, the heterogeneous nature of the disease and the presence of various phenotypes make the treatment of asthma challenging and nuanced. Despite the availability of several approved pharmacological treatments, approximately half of patients with asthma in the United States experienced exacerbations in 2016, highlighting the need for effective add-on treatments. Furthermore, asthma control remains suboptimal due to low adherence to medications, poor inhaler technique, and several patient-related factors. Importantly, the primary care setting, in which pharmacists play an integral role, represents a critical environment for providing long-term follow-up care for the effective management of chronic diseases, such as asthma. Pharmacists are uniquely positioned to ensure optimal clinical outcomes in patients with asthma since they have the clinical expertise to educate patients on their disease state and the role of asthma medications, provide training on inhalation technique, address patients' concerns about potential side effects of medications, and improve adherence to therapy. Therefore, in this review article, we discuss the overall role of pharmacists in effective asthma care and management.
引用
收藏
页码:149 / 162
页数:14
相关论文
共 101 条
  • [41] Effects of an Asthma Self-Management Support Service Provided by Community Pharmacists: A Systematic Review and Meta-Analysis
    Dokbua, Suthasinee
    Dilokthornsakul, Piyameth
    Chaiyakunapruk, Nathorn
    Saini, Bandana
    Krass, Ines
    Dhippayom, Teerapon
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (11) : 1184 - 1196
  • [42] Incidence and prevalence of adult asthma is associated with low socio-economic status
    Ekerljung, Linda
    Sundblad, Britt-Marie
    Ronmark, Eva
    Larsson, Kjell
    Lundback, Bo
    [J]. CLINICAL RESPIRATORY JOURNAL, 2010, 4 (03) : 147 - 156
  • [43] A study of a multi-level intervention to improve non-adherence in difficult to control asthma
    Gamble, Jacqueline
    Stevenson, Michael
    Heaney, Liam G.
    [J]. RESPIRATORY MEDICINE, 2011, 105 (09) : 1308 - 1315
  • [44] Environmental triggers and avoidance in the management of asthma
    Gautier, Clarisse
    Charpin, Denis
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2017, 10 : 47 - 56
  • [45] Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers
    Ghosh, Sohini
    Ohar, Jill A.
    Drummond, M. Bradley
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (06) : 381 - 387
  • [46] Written action plans for asthma: an evidence-based review of the key components
    Gibson, PG
    Powell, H
    [J]. THORAX, 2004, 59 (02) : 94 - 99
  • [47] Global Initiative for Asthma, POCK GUID ASTHM MAN
  • [48] Evaluation of the impact of a pharmaceutical care program in children with asthma
    González-Martin, G
    Joo, I
    Sánchez, I
    [J]. PATIENT EDUCATION AND COUNSELING, 2003, 49 (01) : 13 - 18
  • [49] Gregory KL, 2017, PULMONARY DIS AEROSO
  • [50] Harkins M, 2011, CHEST, V140, p861A, DOI [10.1378/chest.1107313, DOI 10.1378/CHEST.1107313]